These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7509465)

  • 41. A comparison of actions of neuropeptide Y (NPY) agonists and antagonists at NPY Y1 and Y2 receptors in anaesthetized rats.
    Smith-White M; Moriarty MJ; Potter EK
    Neuropeptides; 1998 Apr; 32(2):109-18. PubMed ID: 9639248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropeptide Y 16-36 inhibits mucociliary activity but does not affect blood flow in the rabbit maxillary sinus in vivo.
    Cervin A
    Regul Pept; 1992 Jun; 39(2-3):237-46. PubMed ID: 1438973
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.
    Greber S; Schwarzer C; Sperk G
    Br J Pharmacol; 1994 Nov; 113(3):737-40. PubMed ID: 7858862
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    J Neurochem; 2001 Oct; 79(2):286-96. PubMed ID: 11677256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
    Haynes JM; Hill SJ; Selbie LA
    Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microinjections of subpicomolar amounts of NPY(13-36) into the nucleus tractus solitarius of the rat counteract the vasodepressor responses of NPY(1-36) and of a NPY Y1 receptor agonist.
    Yang SN; Narváez JA; Bjelke B; Agnati LF; Fuxe K
    Brain Res; 1993 Sep; 621(1):126-32. PubMed ID: 8221064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
    Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
    Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
    Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
    Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
    J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of vascular neuropeptide Y receptors.
    Grundemar L; Jonas SE; Mörner N; Högestätt ED; Wahlestedt C; Håkanson R
    Br J Pharmacol; 1992 Jan; 105(1):45-50. PubMed ID: 1317737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of neuropeptide Y-induced feeding: dissociation of Y1 and Y2 receptor effects on natural meal patterns.
    Leibowitz SF; Alexander JT
    Peptides; 1991; 12(6):1251-60. PubMed ID: 1667688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
    Grundemar L
    Regul Pept; 1997 Aug; 71(2):97-101. PubMed ID: 9416991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
    Holliday ND; Cox HM
    Br J Pharmacol; 1996 Sep; 119(2):321-9. PubMed ID: 8886416
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coinjections of NPY(1-36) or [Leu31,Pro34]NPY with adrenaline in the nucleus tractus solitarius of the rat counteract the vasodepressor responses to adrenaline.
    Yang SN; Fior DR; Hedlund PB; Narváez JA; Agnati LF; Fuxe K
    Neurosci Lett; 1994 Apr; 171(1-2):27-31. PubMed ID: 8084492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropeptide Y receptor subtypes, Y1 and Y2.
    Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
    Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms.
    Yu XJ; Moskowitz MA
    Br J Pharmacol; 1996 Sep; 119(2):229-32. PubMed ID: 8886402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa.
    Bernet F; Maubert E; Bernard J; Montel V; Dupouy JP
    Regul Pept; 1994 Aug; 52(3):187-93. PubMed ID: 7800851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
    Grundemar L; Krstenansky JL; Håkanson R
    Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.